Synthesis and resolution of 2-methyl analogues of GABA
摘要:
E-4-Amino-2-methylbut-2-enoic acid, (+/-)-4-amino-2-methylbutanoic acid, (+)-(S)- and (-)-(R)-4-amino-2-methylbutanoic acid, which are analogues of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid, 4-aminobutanoic acid), were synthesised from ethyl 2-methyl-4-phthalimidobut-2-enoate, ethyl 2-methyl-4-phthilimidobutanoate, (+)+2R-(3,3-dimethylbutyro-1,4-lactonyl)]-(2S)-methyl-4-phthalimidobutanoate and (-)-[(2R-(3,3-dimethylbutyro-1,4-lactonyl)]-(2R)-methyl-4-phthalimidobutanoate, respectively. The assignment of the absolute configuration of (+)-(S)- and (-)-(R)-4-amino-2-methylbutanoic acid was based on the X-ray crystallographic structure of the (+)-(R,S)-diastereoisomer, and direct comparison of specific rotations with the published data for (-)-(R)-4-amino-2-methylbutanoic acid. (C) 2004 Elsevier Ltd. All rights reserved.
Synthesis and resolution of 2-methyl analogues of GABA
摘要:
E-4-Amino-2-methylbut-2-enoic acid, (+/-)-4-amino-2-methylbutanoic acid, (+)-(S)- and (-)-(R)-4-amino-2-methylbutanoic acid, which are analogues of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid, 4-aminobutanoic acid), were synthesised from ethyl 2-methyl-4-phthalimidobut-2-enoate, ethyl 2-methyl-4-phthilimidobutanoate, (+)+2R-(3,3-dimethylbutyro-1,4-lactonyl)]-(2S)-methyl-4-phthalimidobutanoate and (-)-[(2R-(3,3-dimethylbutyro-1,4-lactonyl)]-(2R)-methyl-4-phthalimidobutanoate, respectively. The assignment of the absolute configuration of (+)-(S)- and (-)-(R)-4-amino-2-methylbutanoic acid was based on the X-ray crystallographic structure of the (+)-(R,S)-diastereoisomer, and direct comparison of specific rotations with the published data for (-)-(R)-4-amino-2-methylbutanoic acid. (C) 2004 Elsevier Ltd. All rights reserved.
Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation of S1P family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.
Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation of S1P family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.
There are provided a water dispersion containing colorant-containing water-insoluble vinyl polymer particles, as well as a water-based ink containing the water dispersion. The water-insoluble vinyl polymer is a polymer containing constitutional units represented by the formulae (1) and (2):
wherein R
1
is a hydrogen atom or a methyl group; and R
2
is a substituted or unsubstituted arylalkyl group or a substituted or unsubstituted aryl group; and
wherein R
3
is a hydrogen atom or a methyl group; R
4
O is an oxypropylene group; R
5
O is an oxyalkylene group having 2 or 4 carbon atoms; R
6
is a hydrogen atom, an alkyl group or an unsubstituted or alkyl-substituted phenyl group; x is a number from 1 to 30; and y is a number from 0 to 30, with the proviso that a weight ratio of the constitutional units of formula (1) to formula (2) in the polymer ranges from 1/2 to 10/1.
本发明提供了一种含有含着色剂的水不溶性乙烯基聚合物颗粒的水分散体,以及一种含有该水分散体的水基油墨。水不溶性乙烯基聚合物是一种含有由式(1)和(2)表示的构型单元的聚合物:
其中 R
1
是氢原子或甲基;R
2
是取代或未取代的芳烷基或取代或未取代的芳基;以及
其中 R
3
是氢原子或甲基
4
O 是氧丙烯基团; R
5
O 是具有 2 个或 4 个碳原子的氧亚烷基
6
是氢原子、烷基或未取代或烷基取代的苯基;x 是 1 至 30 之间的数字;y 是 0 至 30 之间的数字,但聚合物中式 (1) 和式 (2) 结构单元的重量比为 1/2 至 10/1。
Aqueous dispersions containing graft copolymers as the dispersant
申请人:E.I. DU PONT DE NEMOURS AND COMPANY
公开号:EP0826751B1
公开(公告)日:2004-04-28
Aqueous pigmented ink jet inks for printing on vinyls